{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:31:01Z","timestamp":1792978261663,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Qiantang Scholars Fund in Hangzhou City University","award":["No. 210000-581835"],"award-info":[{"award-number":["No. 210000-581835"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liquid biopsy, an advanced technology for analyzing body fluid samples, is gaining traction in cancer diagnostics and monitoring. Blood-based liquid biopsy, particularly focusing on cell-free DNAs (cf-DNAs), circulating tumor cells (CTCs), and extracellular vesicles (EVs), has garnered significant attention. EVs stand out for their potential in tumor diagnosis, prognosis prediction, and treatment response assessment, owing to their stable molecular cargo and clear extraction process. At the recent American Association for Cancer Research (AACR) Annual Meeting 2024, groundbreaking EVs-based liquid biopsy studies showcased promising strides in early detection and diagnosis of various cancers, including breast cancer (BC), high-grade serous ovarian cancer (HGSOC), pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), colon adenocarcinoma (COAD), head and neck cancer (HNC), neuroblastoma, and retinoblastoma (RB). Despite these advancements, challenges persist in translating EVs biomarkers into clinical practice. Overcoming these challenges promises to propel EVs-based liquid biopsy into a new era of personalized precision medicine, revolutionizing cancer detection, monitoring, and treatment.<\/jats:p>","DOI":"10.1186\/s13045-024-01577-y","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:29:59Z","timestamp":1722263399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR Annual Meeting 2024"],"prefix":"10.1186","volume":"17","author":[{"given":"Xinming","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"issue":"6Supplement","key":"1577_CR1","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1158\/1538-7445.AM2024-2436","volume":"84","author":"JY Kim","year":"2024","unstructured":"Kim JY, Kim MW, Kim Y, Moon S, Lee S, Lee H, et al. Abstract 2436: In-depth analysis of microRNA signature in breast cancer derived extracellular vesicles: a potential biomarker repository for breast cancer diagnosis. Cancer Res. 2024;84(6Supplement):2436.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR2","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1158\/1538-7445.AM2024-1072","volume":"84","author":"B Cardinali","year":"2024","unstructured":"Cardinali B, Piccioli P, Boccardo F, Rubagotti A, Zinoli L, Sciutto A, et al. Abstract 1072: the EsomiR project: a case control study to assess the role of exosomal miRNAs in breast cancer cancerogenesis. Cancer Res. 2024;84(6Supplement):1072.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR3","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1158\/1538-7445.AM2024-1843","volume":"84","author":"MW Kim","year":"2024","unstructured":"Kim MW, Kim JY, Kim Y, Lee S, Moon S, Hyon J-y, et al. Abstract 1843: integrating machine learning with microfluidic technologies for proteomic profiling of extracellular vesicles in triple-negative breast cancer. Cancer Res. 2024;84(6Supplement):1843.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/1538-7445.AM2024-1070","volume":"84","author":"M Lightfoot","year":"2024","unstructured":"Lightfoot M, Dorayappan KDP, Yu L, Hisey C, Sakaue T, Anbalagan M, et al. Abstract 1070: overcoming deficiencies in the early detection of high grade serous ovarian cancer: evaluating exosomal proteins as novel biomarkers of disease. Cancer Res. 2024;84(6Supplement):1070.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1158\/1538-7445.AM2024-1066","volume":"84","author":"AD Couvillon","year":"2024","unstructured":"Couvillon AD, Winn-Deen ES, Thornton S, Liu S, DeRan M, Pacula M, et al. Abstract 1066: colocalization of ovarian cancer-associated biomarkers in tumors, cancer cells and extracellular vesicles. Cancer Res. 2024;84(6Supplement):1066.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR6","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1158\/1538-7445.AM2024-2418","volume":"84","author":"R Uekusa","year":"2024","unstructured":"Uekusa R, Yokoi A, Yoshida K, Matsuazki J, Yamamoto Y, Kajiyama H. Abstract 2418: Copy number variation status of DNA in extracellular vesicles as novel biomarkers of high-grade serous ovarian carcinoma. Cancer Res. 2024;84(6Supplement):2418.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR7","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1158\/1538-7445.AM2024-4635","volume":"4635","author":"F Guo","year":"2024","unstructured":"Guo F, Zhang S, Li P, Abstract. RNF208: a novel diagnostic and prognostic biomarker for colorectal cancer and key regulator of malignant behavior. Cancer Res. 2024;4635(6Supplement):4635.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR8","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1158\/1538-7445.AM2024-3637","volume":"84","author":"L Hebert","year":"2024","unstructured":"Hebert L, Al-Ameen M, Spriggs T, Nelson C, Gizzie EA, Franklin JL, et al. Abstract 3637: ultrasensitive assays for combined detection of CEA\u2009+\u2009extracellular vesicles and soluble CEA. Cancer Res. 2024;84(6Supplement):3637.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/1538-7445.AM2024-1038","volume":"84","author":"Y Seo","year":"2024","unstructured":"Seo Y, Han YD, Bojmar L, Kim K-A, Seo Y, Lyden D, Kim HS. Abstract 1038: identification of diagnostic biomarkers for colon adenocarcinoma by analyzing proteins in human-derived extracellular vesicles and particles. Cancer Res. 2024;84(6Supplement):1038.","journal-title":"Cancer Res"},{"issue":"5","key":"1577_CR10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, et al. An exosome-based Transcriptomic Signature for Noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a Multicenter Cohort Study. Gastroenterology. 2022;163(5):1252\u2013e662.","journal-title":"Gastroenterology"},{"issue":"6Supplement","key":"1577_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/1538-7445.AM2024-1074","volume":"84","author":"S Bansal","year":"2024","unstructured":"Bansal S, Wang S, Li Y, Bansal S, Smith J, Tyburski JB, et al. Abstract 1074: plasma EV profiling facilitates low abundance biomarker discovery in pancreatic cancer. Cancer Res. 2024;84(6Supplement):1074.","journal-title":"Cancer Res"},{"issue":"6Supplement","key":"1577_CR12","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1158\/1538-7445.AM2024-2497","volume":"84","author":"K Halder","year":"2024","unstructured":"Halder K, Jameson G, Borazanci E, Lin W, Cridebring D, Von Hoff D, Han H. Abstract 2497: extracellular vesicle based ALPPL2 and THBS2 as biomarkers for disease monitoring in patients with pancreatic ductal adenocarcinoma. Cancer Res. 2024;84(6Supplement):2497.","journal-title":"Cancer Res"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-024-01577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-024-01577-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-024-01577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:31:04Z","timestamp":1722263464000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-024-01577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1186\/s13045-024-01577-y","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}